Purpose: The aim of the study was to present the computed tomography (CT) and fluorine 18 ( Results: Multiple and solitary lesions were detected in 15 and 3 patients, respectively. Of those patients with multiple pulmonary lesions, 12 were bilateral, and 3 were unilateral. A total of 51 pulmonary lesions were identified in 18 patients, which included lesions with consolidation (31/51), mass and nodule (12/51), and ground-glass attenuation (8/51).
T he term mucosa-associated lymphoid tissue (MALT) refers to the subepithelial lymphoid tissue of the gastrointestinal, respiratory, and urogenital tracts and their analogs. Pulmonary MALT does not exist in normal physiological conditions. However, pulmonary MALT can develop upon chronic inflammatory stimulation and in diseases caused by chronic dysfunction of B cells (eg, Sjögren syndrome and rheumatoid arthritis) and may result in pulmonary MALT lymphoma. 1 Pulmonary MALT lymphoma occurs rarely: the incidence rate is less than 1% of all cases of lymphoma. 2 Because of indolent and relatively benign characteristics, pulmonary MALT lymphoma was once called pseudolymphoma. 1 With the advent of new diagnostic technologies, pulmonary MALT lymphoma was confirmed to be a low-grade extranodal B-cell primary lymphoma and was classified by the World Health Organization (WHO) as an extranodal marginal-zone lymphoma of the MALT. 3 The imaging findings associated with pulmonary MALT lymphoma were diverse, and few reports have been published on computed tomography (CT) imaging findings of pulmonary MALT lymphoma. 4Y10 Familiarity with the imaging findings of pulmonary MALT lymphoma can facilitate the differentiation of this disease from other pulmonary diseases.
Fluorine 18 ( 18 F) fluorodeoxyglucoseYpositron emission tomography (FDG-PET), which is based on functional rather than morphological mapping, plays an important role in the management of many malignancies. However, the low spatial resolution of 18 F FDG-PET limits the accuracy of determining the anatomical location of the identified lesions. Hybrid FDG-PET/CT imaging provides both functional and morphological information and has been widely used for diagnosis, staging, and evaluating the treatment response in many malignant diseases. Previous studies reported conflicting data regarding FDG uptake of pulmonary MALT lymphoma. 11Y16 We retrospectively reviewed the CT and FDG-PET/CT imaging findings of 18 cases of pulmonary MALT lymphoma and evaluated their roles in the follow-up of this tumor.
PATIENTS AND METHODS
From our hospital database, we identified patients who had received treatment at our hospital between January 2000 and August 2009. In total, 18 patients with pulmonary MALT lymphoma were included in this study. To perform this retrospective study, we obtained exemption and waiver of the requirement of obtaining written informed consent from the institutional review board.
All 18 patients underwent thoracic, abdominal, and pelvic CT, and 8 patients also underwent FDG-PET/CT at diagnosis. Fifteen patients underwent thoracic CT, and 4 patients also underwent FDG-PET/CT during the 12-to 84-month follow-up period.
Computed tomography imaging was performed using Brilliance TM16 helical scanner (Philips Medical Systems, Best, the Netherlands). The scan parameters were as follows: 5-mm slice reconstruction, 23-cm field of view, 120 JV, 200-to 300-mA current, and 256 Â 256 matrix. All 18 patients had undergone unenhanced and contrast-enhanced CT scans. In patients scheduled for contrast-enhanced CT scanning, an intravenous bolus dose of 100 mL of a nonionic iodinated contrast agent (iopromide [Ultravist]; Schering, Shanghai, China) was administered at 2.5 mL/s. Arterial-phase abdominal contrast-enhanced CT scans were obtained at 30 seconds after administration of the contrast agent, and thoracic, portal-phase abdominal, and pelvis contrast-enhanced CT scans were obtained at 50 seconds after contrast agent injection.
FluorodeoxyglucoseYPET/CT imaging was performed using a dedicated PET/CT system (Discovery ST-16; General Electric Medical System, Milwaukee, Wis). Patients were instructed to fast for 6 hours prior to 18 F-FDG injection. Blood glucose was measured before the injection of the tracer to ensure that the glucose levels were less than 8.1 mmol/L. We injected Computed tomography was performed prior to PET, and the resulting data were used to generate a PET attenuation correction map. Positron emission tomography images were reconstructed with a slice thickness of 3.75 mm using the iterative orderedsubsets expectation maximization method. Positron emission tomography, CT, and fused PET/CT images were generated for review on a Xeleris computer workstation (General Electric Medical System, Milwaukee, Wis).
Two experienced radiologists reviewed each lesion on the CT and FDG-PET/CT images for tumor number, distribution, shape, attenuation, and other associated findings. For FDG-PET/CT imaging analysis, the maximal standardized uptake value (SUV max ) values of FDG uptake for each lesion was recorded.
Tumor lesion characteristics on imaging are defined as 8 (1) mass: well-defined or moderately well-defined, round or round-like opacity; diameter of greater than 3 cm; (2) nodule: well-defined or moderately well-defined, round or round-like opacity; diameter of less than 3 cm; (3) consolidation: homogeneous density that obscures the vessel margins and airway walls; (4) ground-glass opacity: hazy increased density that does not obscure vessel margins or airway walls; (5) CT angiogram sign: enhanced vascularity in the consolidation; and (5) lymph node: considered enlarged if the short axis-diameter is greater than 1 cm.
RESULTS

Clinical Data
The study group consisted of 10 men and 8 women with a mean age of 57 years (range, 37Y77 years). Of the 18 patients, FIGURE 7 . Axial CT scan of patient in Figure 2 demonstrates lower paratracheal, aortopulmonary window lymphadenopathy, which is not proved by biopsy or FDG-PET/CT imaging. 9 presented with thoracic discomfort and dry cough, 2 were identified while being evaluated for other disease, and 7 were identified during routine checkups.
CT Imaging Findings
Fifty-one pulmonary lesions, including consolidation, mass, nodule, and ground-glass attenuation, were identified in 18 patients. Multiple lesions were observed in 15 of 18 patients, and solitary lesions were observed in the remaining 3 patients. Of the 15 patients with multiple lesions, 3 demonstrated unilateral pulmonary lesions, and the remaining 12 demonstrated bilateral lesions. Lesions were in the right upper lung (n = 7), right middle lung (n = 9), right lower lung (n = 9), left upper lung (n = 8), lingular segments (n = 10), and left lower lung (n = 8).
A total of 31 consolidation lesions with air bronchogram were detected in 13 cases (Fig. 1) , 2 of which demonstrated 6 lesions with bronchial dilation (Fig. 2) . Twenty-five lesions were segmented, and 6 were lobular. Six cases included a total of 12 masses or nodular lesions, of which 8 showed air bronchogram (Fig. 3) . Size ranged from 21 Â 26 to 38 Â 43 mm. Two cases demonstrated 8 ground-glass-opacity lesions (Fig. 4) . Two cases showed CT angiogram sign (Fig. 5) . One case demonstrated multiple bilateral cystic lung lesions (Fig. 6) .
Of the 18 patients, 1 case demonstrating multiple lung consolidations and ground-glass opacity also showed lower paratracheal, aortopulmonary window, subcarinal, paraesophageal, and hilar lymphadenopathy (Fig. 7) . But this case did not undergo FDG-PET/CT imaging and biopsy.
FDG-PET/CT Imaging
FluorodeoxyglucoseYPET/CT images revealed increased FDG uptake in pulmonary consolidation, mass, and nodular lesions in all 8 cases, which corresponded with findings on the CT images. The lesion SUV max ranged from 2.8 to 9.4 (mean SUV max , 4.9) (Fig. 8) . No foci of increased FDG uptake were 
Treatment and Follow-Up
Of the 18 cases, 3 underwent simple surgery, 2 received surgery and chemotherapy, 7 received chemotherapy, 4 received radiotherapy and chemotherapy, and 2 received no treatment. Three cases experienced complete remission, 10 had partial remission (Fig. 9) , 2 remained stable without treatment, and 3 cases were lost to follow-up.
Microscopy and Immunohistochemistry
All of the resected tumors in 5 cases were nonencapsulated. The cut surfaces were gray-yellow. Microscopically, the tumor consisted of diffuse small round cells. The tumor cells were usually small to medium, were round or oval, and had scant cytoplasm and round or slightly irregular nuclei (Fig. 10) . Immunohistochemical examination revealed all 18 cases as positive for L26 and LCA, 17 cases positive for CD79 a, and 15 cases positive for UCHL1, whereas all 18 cases were negative for CD5, and 16 cases were negative for cyclin D1, CD10, and CD23.
DISCUSSION
Pulmonary MALT lymphoma often affects middle-aged to elderly adults and shows no characteristic presentation. In the Wislez report, 2 8 patients presented with dry cough and weight loss; the other 5 patients demonstrated no symptoms. In our patient series, ages ranged from 37 to 77 years (mean, 57 years). The main symptoms presented by patients were dry cough and thoracic discomfort; pulmonary MALT in 7 asymptomatic patients was incidentally discovered in routine checkup.
The CT imaging findings of pulmonary MALT lymphoma were diverse and often presented multiple lesions with no lobular predilection. The most common imaging findings were consolidation, followed by mass and nodule. Other findings included ground-glass opacity and interstitial change. The most common accompanying findings were air bronchogram and bronchial dilation 8, 9 (Table 1 ). In the report by Kinsely et al, 9 7 of the 11 patients demonstrated consolidation with air bronchogram, 6 demonstrated nodule, 5 demonstrated ground-glass opacity, 3 demonstrated bronchiectasis and bronchiocele, and 3 demonstrated mass. In the report by Bae et al, 4 the common imaging findings included consolidation in 11 cases (52%), nodule in 8 cases (38%), ground-glass opacity in 8 cases (38%), and bronchiectasis in 3 cases (14%). In our series, 51 pulmonary lesions with no lobar predilection were identified. Of the 18 patients, 13 demonstrated consolidation, 6 demonstrated mass or nodular lesions, 2 demonstrated ground-glass opacity, 1 demonstrated bronchiectasis, and 2 showed CT angiogram sign, all of which were similar to previous reports. 4, 8, 9 The imaging-histopathology correlation studies of pulmonary MALT lymphoma 2, 8 showed that diverse imaging findings were explained by the expansion and destruction of the alveolar wall and filling of alveolar space secondary to tumor tissue infiltration along bronchovascular and interlobular septa. Mass, nodule, and consolidation were caused by alveolar space filling; bronchogram and CT angiogram sign were caused by undestroyed airway, vascular in mass, nodule, and consolidation; and ground-glass opacity was caused by lymphomatous infiltration of interlobular septa and alveolar walls. Bronchial dilation associated with pulmonary MALT lymphoma is different from traditional bronchiectasis. The study of Wislez et al 2 showed common clinical presentation of pulmonary MALT lymphoma as a dry cough, with bronchial dilation often occurring in mass or consolidation lesions and often disappearing by posttreatment follow-up. Upon histopathologic examination, the bronchial dilation walls did not show signs of destruction, which suggested that bronchial dilation resulted from the alveoli collapse and destruction of peribronchial parenchyma secondary to lymphomatous infiltration. In our patient series, 2 patients showed 6 lesions with bronchial dilation, neither of which disappeared by the 15-and 18-month follow-up, respectively.
Bronchovascular thickening due to lymphomatous infiltration can produce varied imaging findings regarding the extent and location of lesions. In a high-resolution pulmonary MALT lymphoma CT study, 10 5 patients showed accompanying interlobular septa thickening, and 2 patients showed central lobular nodularity and peribronchovascular thickening. Similar interstitial findings were also reported in the study of Bae et al. 4 In our patient series, high-resolution CT is not performed, and as such, 5 cases demonstrated bronchovascular thickening but no central lobular micronodularity.
Distinct differences exist between pulmonary MALT and lymphatic tissues in lymph node. Pulmonary MALT lymphoma rarely involves mediastinal and hilar lymph nodes. In the report of Kinsely et al, 9 1 of 11 patients demonstrated mediastinal and axillary lymphadenopathy. In the report of Bae et al, 4 1 of 21 patients demonstrated mediastinal and hilar lymphadenopathy, which was nodular rather than infiltrating lymphoma as confirmed by biopsy.
Cystic lung lesion is a less common finding. In the Bae report, 4 3 of 21 patients demonstrated cystic lung lesions. In our series, only 1 patient demonstrated multiple cystic lung lesions.
Pleural effusion is not a common finding. Previous reports 4, 9 show pleural effusion incidence rates of 2 of 11 and 2 of 21. In our patient series, pleural effusion was demonstrated in 3 cases.
There are conflicting reports on FDG uptake in extranodal marginal zone B-cell lymphoma ( Table 2 ). The reports by Hoffmann et al 11, 12 did not show FDG uptake in pulmonary MALT lymphoma; however, Beal et al 16 lymphoma with plasmacytic differentiation would have a higher proportion of FDG uptake. In our series, all 8 patients who underwent FDG-PET/CT imaging showed significant FDG uptake, with lesion SUV max ranging from 2.8 to 9.4. Pulmonary MALT lymphoma develops slowly, and the prognosis is favorable. The treatment methods include surgery, chemotherapy, and radiotherapy. Most of the 14 patients with pulmonary MALT lymphoma did not develop by the 9.5-month follow-up in the report of Bae et al. 4 In our series, 3 surgical patients experienced complete remission, 10 patients experience partial remission, and 2 patients were stable without treatment.
The CT imaging findings of pulmonary MALT lymphoma were diverse and should be differentiated from inflammatory bronchioloalveolar carcinoma, tuberculosis, organized pneumonia, and lymphoproliferative disease. However, multiple, bilateral pulmonary consolidations, masses, or nodules with air bronchogram on CT images associated with an indolent clinical period may imply pulmonary MALT lymphoma.
CONCLUSIONS
Computed tomography and FDG-PET/CT images of the pulmonary MALT lymphoma usually reveal multiple, bilateral consolidations, masses, or nodules with air bronchogram and increased FDG uptake. Computed tomography and FDG-PET/ CT imaging play important roles in the diagnosis and follow-up of pulmonary MALT lymphoma.
